BFC Planning’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$89 Hold
3
– – ﹤0.01% 3395
2026
Q2
$90 Buy
+3
New +$85 ﹤0.01% 3357

Other funds holding LKFT

BFC Planning's LKFT Position: Q3 2026 in Review

BFC Planning held its Lakefront Biotherapeutics American Depositary Shares (LKFT) position steady in Q3 2026 at 3 shares worth $89. The position accounts for ﹤0.01% of the portfolio, ranked #3395.

BFC Planning first reported a position in LKFT in Q2 2026 and has held it in 2 quarters since. The position peaked at $90 in Q2 2026. 67 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

  • BFC Planning held 3 shares of Lakefront Biotherapeutics American Depositary Shares worth $89 as of Q3 2026.
  • BFC Planning left its Lakefront Biotherapeutics American Depositary Shares share count unchanged in Q3 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3395 holding.
  • BFC Planning first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2026 and has held it in 2 quarters since.
  • BFC Planning's Lakefront Biotherapeutics American Depositary Shares position peaked at $90 in Q2 2026.
  • 67 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.